{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:36:33Z","timestamp":1778214993496,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["409691\/2006-2"],"award-info":[{"award-number":["409691\/2006-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministerio da Saude","award":["3072\/2007"],"award-info":[{"award-number":["3072\/2007"]}]},{"name":"Funda\u00e7ao Pro HEMORIO","award":["188\/13"],"award-info":[{"award-number":["188\/13"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.bcmd.2015.01.011","type":"journal-article","created":{"date-parts":[[2015,2,23]],"date-time":"2015-02-23T19:53:09Z","timestamp":1424721189000},"page":"321-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Severity of Brazilian sickle cell disease patients: Severity scores and feasibility of the Bayesian network model use"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6478-8173","authenticated-orcid":false,"given":"Edis","family":"Belini Junior","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo Gr\u00fcnig Humberto","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4598-1899","authenticated-orcid":false,"given":"Lidiane de Souza","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9ssika Viviani","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarisse Lopes de Castro","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Regina","family":"Bonini-Domingos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2015.01.011_bb0005","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","article-title":"Sickle-cell disease","volume":"364","author":"Stuart","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0010","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/adc.67.4.517","article-title":"Fetal haemoglobin and early manifestations of homozygous sickle cell disease","volume":"67","author":"Bailey","year":"1992","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0020","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/bjo.74.3.172","article-title":"Risk factors for proliferative sickle retinopathy","volume":"74","author":"Fox","year":"1990","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0025","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle-cell-anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0030","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0035","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/adc.85.5.375","article-title":"Sickle cell disease and age at menarche in Jamaican girls: observations from a cohort study","volume":"85","author":"Serjeant","year":"2001","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0040","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM198206173062402","article-title":"The interaction of alpha-thalassemia and homozygous sickle-cell disease","volume":"306","author":"Higgs","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0045","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2141.1991.tb08628.x","article-title":"Acute splenic sequestration in Jamaican adults with homozygous sickle cell disease: a role of alpha thalassaemia","volume":"77","author":"De Ceulaer","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000022899","article-title":"\u03b1-Thalassemia in Bantu population from Congo-Brazzaville: its interaction with sickle cell anemia","volume":"50","author":"Mou\u00e9l\u00e9","year":"2000","journal-title":"Hum. Hered."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0055","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/00043426-200308000-00007","article-title":"Alpha thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia","volume":"25","author":"Hsu","year":"2003","journal-title":"J. Pediatr. Hematol. Off. J. Am. Soc. Pediatr. Hematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0060","first-page":"178","article-title":"The influence of alpha-thalassaemia on the haematological & clinical expression of sickle cell disease in western India","volume":"107","author":"Mukherjee","year":"1998","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0065","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.10140","article-title":"Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors","volume":"70","author":"Powars","year":"2002","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0070","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2003-09-3015","article-title":"Gene interactions and stroke risk in children with sickle cell anemia","volume":"103","author":"Hoppe","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0075","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/STROKEAHA.107.483115","article-title":"Confirmation of an association between the TNF(\u2212308) promoter polymorphism and stroke risk in children with sickle cell anemia","volume":"38","author":"Hoppe","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0080","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2141.2006.06074.x","article-title":"Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta\/BMP pathway","volume":"133","author":"Nolan","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0085","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1097\/00003246-199911000-00039","article-title":"Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent","volume":"27","author":"Sullivan","year":"1999","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0090","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1096-8652(199812)59:4<267::AID-AJH1>3.0.CO;2-W","article-title":"Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease","volume":"59","author":"Zimmerman","year":"1998","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0095","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1586\/ehm.10.44","article-title":"Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment","volume":"3","author":"Fertrin","year":"2010","journal-title":"Expert. Rev. Hematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0100","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1365-2141.2003.04762.x","article-title":"Association of T-786C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease","volume":"124","author":"Sharan","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0105","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1182\/blood-2001-12-0306","article-title":"Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease","volume":"100","author":"Taylor","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0110","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1182\/blood-2003-07-2475","article-title":"Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease","volume":"103","author":"Zimmerman","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0115","series-title":"Predictors of Fetal Hemoglobin Response in Children With Sickle Cell Anemia Receiving Hydroxyurea Therapy","author":"Ware","year":"2002"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0120","series-title":"Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia: Risks and Benefits up to 9years of Treatment","author":"Steinberg","year":"2003"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5year follow-up","volume":"85","author":"Steinberg","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1477-7525-4-59","article-title":"Hydroxyurea and sickle cell anemia: effect on quality of life","volume":"4","author":"Ballas","year":"2006","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1100\/tsw.2009.10","article-title":"Genetic etiologies for phenotypic diversity in sickle cell anemia","volume":"9","author":"Steinberg","year":"2009","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0140","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015032","article-title":"The search for genetic modifiers of disease severity in the beta-hemoglobinopathies","volume":"2","author":"Lettre","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0145","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/ajh.21846","article-title":"Development and validation of a pediatric severity index for sickle cell patients","volume":"85","author":"van den T","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0150","first-page":"483","article-title":"Evaluation of clinical severity in sickle cell disease","volume":"75","author":"Cameron","year":"1983","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0609.2011.01705.x","article-title":"The alpha-globin genotype does not influence sickle cell disease severity in a retrospective cross-validation study of the pediatric severity score","volume":"88","author":"Joly","year":"2012","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0160","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s10286-005-0300-9","article-title":"Autonomic reactivity and clinical severity in children with sickle cell disease","volume":"15","author":"Pearson","year":"2005","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0165","first-page":"8","article-title":"Extent of silent cerebral infarcts in adult sickle-cell disease patients on magnetic resonance imaging: is there a correlation with the clinical severity of disease?","volume":"5","author":"Solomou","year":"2013","journal-title":"Neuroradiol. J."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0170","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/ejh.12011","article-title":"Sickle cell disease severity scoring: a yet unsolved problem","volume":"89","author":"Coelho","year":"2012","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0175","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1182\/blood-2007-04-084921","article-title":"A network model to predict the risk of death in sickle cell disease","volume":"110","author":"Sebastiani","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0180","author":"BRAZIL"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0185","author":"BRAZIL"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0190","doi-asserted-by":"crossref","first-page":"822","DOI":"10.5114\/aoms.2010.17101","article-title":"The XmnI polymorphic site 5\u2032 to the gene G(gamma) in a Brazilian patient with sickle cell anaemia \u2014 fetal haemoglobin concentration, haematology and clinical features","volume":"6","author":"Belini","year":"2010","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0195","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2141.2003.03849.x","article-title":"The role of hydroxyurea in sickle cell disease","volume":"120","author":"Halsey","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0200","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/bjh.12323","article-title":"The effect of hydroxcarbamide therapy on survival of children with sickle cell disease","volume":"161","author":"Lopes de Castro Lobo","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0205","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3324\/haematol.2012.068965","article-title":"The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe","volume":"98","author":"Nouraie","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0210","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI30920","article-title":"Sickle cell disease: old discoveries, new concepts, and future promise","volume":"117","author":"Frenette","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0215","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00062752-199502020-00001","article-title":"Natural history and determinants of clinical severity of sickle cell disease","volume":"2","author":"Serjeant","year":"1995","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0220","doi-asserted-by":"crossref","first-page":"a011783","DOI":"10.1101\/cshperspect.a011783","article-title":"The natural history of sickle cell disease","volume":"3","author":"Serjeant","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0225","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(05)73186-X","article-title":"Screening for sickle-cell disease in Brazil","volume":"356","author":"Serjeant","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0230","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0235","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood.V74.4.1403.1403","article-title":"Leg ulcers in patients with sickle cell disease","volume":"74","author":"Koshy","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0240","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1100\/tsw.2008.157","article-title":"Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches","volume":"8","author":"Steinberg","year":"2008","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ajh.21572","article-title":"Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study","volume":"85","author":"Sebastiani","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0250","series-title":"Bone Marrow Transplantation for Sickle Cell Disease","author":"Walters","year":"1996"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0255","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. Rates and risk factors","volume":"325","author":"Platt","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0260","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ajh.21379","article-title":"Usefulness and limitations of Bayesian network model as a mortality risk assessment tool in sickle cell anemia","volume":"84","author":"Anoop","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0265","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0270","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ajh.21550","article-title":"Definitions of the phenotypic manifestations of sickle cell disease","volume":"85","author":"Ballas","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0275","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0950-3536(98)80075-9","article-title":"7 sickle cell disease: clinical management","volume":"11","author":"Ballas","year":"1998","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0280","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0895-4356(92)90073-V","article-title":"Laboratory profile of sickle cell disease: a cross-sectional analysis. The cooperative study of sickle cell disease","volume":"45","author":"West","year":"1992","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0285","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2012-10-462135","article-title":"Lactate dehydrogenase and hemolysis in sickle cell disease","volume":"121","author":"Ballas","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.01.011_bb0290","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2007.06794.x","article-title":"Sickle-cell haemoglobin polymerization: is it the primary pathogenic event of sickle-cell anaemia?","volume":"139","author":"Vekilov","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0295","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","article-title":"Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions","volume":"84","author":"Kato","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2015.01.011_bb0300","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.21928","article-title":"Severe sickle cell anemia is associated with increased plasma levels of TNF-R1 and VCAM-1","volume":"86","author":"Dworkis","year":"2011","journal-title":"Am. J. Hematol."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979615000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979615000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:30:35Z","timestamp":1761049835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979615000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1079979615000315"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.01.011","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severity of Brazilian sickle cell disease patients: Severity scores and feasibility of the Bayesian network model use","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}